Saxsons Group — India's trusted nuclear medicine, radiotherapy, oncosurgery, dosimetry and cyclotron supplier since 1986

All research papers

2716 approved papers, newest first · showing 2281–2340.Search instead →

  1. 1 Aug 2012· Medical physics· SBRT delivery· QA & dosimetry
    Improvements in dose calculation accuracy for small off-axis targets in high dose per fraction tomotherapy.
    Hardcastle N et al.
  2. 1 Aug 2012· Medical physics· SRS / intracranial· QA & dosimetry
    On the output factor measurements of the CyberKnife iris collimator small fields: Experimental determination of the k(Q(clin),Q(msr) ) (f(clin),f(msr) ) correction factors for microchamber and diode detectors.
    Pantelis E et al.
  3. 1 Aug 2012· Journal of medical imaging and radiation oncology· Breast / lung positioning· Therapeutic
    Deep inspiration breath hold technique reduces heart dose from radiotherapy for left-sided breast cancer.
    Hayden AJ et al.
  4. 1 Aug 2012· Medical physics· Patient-specific QA· QA & dosimetry
    3D DVH-based metric analysis versus per-beam planar analysis in IMRT pretreatment verification.
    Carrasco P et al.
  5. 19 Jul 2012· Bioconjugate chemistry· Cyclotron production· Diagnostic· Radiopharmacy
    Simplified NaCl based (68)Ga concentration and labeling procedure for rapid synthesis of (68)Ga radiopharmaceuticals in high radiochemical purity.
    Mueller D et al.
  6. 10 Jul 2012· Journal of nuclear medicine· Ga-68 DOTATATE· Diagnostic
    Clinical PET of neuroendocrine tumors using 64Cu-DOTATATE: first-in-humans study.
    Pfeifer A et al.
  7. 4 Jul 2012· Radiation protection dosimetry· Personal / occupational dosimetry· Radiation safety
    Eye lens radiation exposure to interventional cardiologists: a retrospective assessment of cumulative doses.
    Jacob S et al.
  8. 1 Jul 2012· Current radiopharmaceuticals· Cyclotron production· Therapeutic· Radiopharmacy
    Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes.
    Morgenstern A et al.
  9. 28 Jun 2012· European journal of nuclear medicine and molecular imaging· Hot-lab shielding· Radiation safety· Radiopharmacy
    Validation of a new protocol for ¹⁸F-FDG infusion using an automatic combined dispenser and injector system.
    Lecchi M et al.
  10. 24 Jun 2012· Radiation oncology (London, England)· SBRT delivery· Therapeutic· Free full text
    Image-guided robotic stereotactic radiation therapy with fiducial-free tumor tracking for lung cancer.
    Bibault JE et al.
  11. 22 Jun 2012· The Lancet. Oncology· SBRT delivery· Therapeutic
    Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.
    Senthi S et al.
  12. 1 Jun 2012· Medical physics· SBRT positioning systems· QA & dosimetry
    SU-D-211-01: Effect of Immobilization/support Devices and Air Gap on Skin Doses for Stereotactic Body Radiotherapy with Abdominal Compression Device.
    Peng Y.
  13. 24 May 2012· AJNR. American journal of neuroradiology· Radiation safety
    The use of adaptive statistical iterative reconstruction in pediatric head CT: a feasibility study.
    Vorona GA et al.
  14. 20 May 2012· Physica medica· SBRT delivery· QA & dosimetry
    Is abdominal compression useful in lung stereotactic body radiation therapy? A 4DCT and dosimetric lobe-dependent study.
    Bouilhol G et al.
  15. 19 May 2012· International journal of radiation oncology, biology, physics· SRS / intracranial· Therapeutic
    International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery.
    Cox BW et al.
  16. 10 May 2012· Journal of applied clinical medical physics· SRS / intracranial· QA & dosimetry· Free full text
    Clinical commissioning and use of the Novalis Tx linear accelerator for SRS and SBRT.
    Kim J et al.
  17. 5 May 2012· International journal of radiation oncology, biology, physics· SRS / intracranial· Therapeutic
    The abscopal effect associated with a systemic anti-melanoma immune response.
    Stamell EF et al.
  18. 1 May 2012· Medical physics· In-vivo dosimetry· QA & dosimetry
    In vivo dosimetry with radiochromic films in low-voltage intraoperative radiotherapy of the breast.
    Avanzo M et al.
  19. 1 May 2012· The New England journal of medicine· I-131 therapy· Therapeutic
    Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.
    Mallick U et al.
  20. 1 May 2012· The New England journal of medicine· I-131 therapy· Therapeutic
    Strategies of radioiodine ablation in patients with low-risk thyroid cancer.
    Schlumberger M et al.
  21. 30 Apr 2012· Applied radiation and isotopes· TLD dosimetry· QA & dosimetry
    Thermoluminescence in medical dosimetry.
    Rivera T.
  22. 24 Apr 2012· Radiation oncology (London, England)· Thermoplastic masks· QA & dosimetry· Free full text
    Dosimetric consequences of translational and rotational errors in frame-less image-guided radiosurgery.
    Guckenberger M et al.
  23. 9 Apr 2012· International journal of radiation oncology, biology, physics· Breast / lung positioning· Therapeutic
    Prone accelerated partial breast irradiation after breast-conserving surgery: five-year results of 100 patients.
    Formenti SC et al.
  24. 9 Apr 2012· International journal of radiation oncology, biology, physics· Breast / lung positioning· Therapeutic· QA & dosimetry
    Prospective assessment of optimal individual position (prone versus supine) for breast radiotherapy: volumetric and dosimetric correlations in 100 patients.
    Lymberis SC et al.
  25. 13 Mar 2012· Radiation oncology (London, England)· Adaptive radiotherapy· QA & dosimetry· Free full text
    3D Variation in delineation of head and neck organs at risk.
    Brouwer CL et al.
  26. 1 Mar 2012· International journal of radiation oncology, biology, physics· SBRT delivery· QA & dosimetry
    Spine stereotactic body radiotherapy utilizing cone-beam CT image-guidance with a robotic couch: intrafraction motion analysis accounting for all six degrees of freedom.
    Hyde D et al.
  27. 20 Feb 2012· Endocrine· Ga-68 DOTATATE· Diagnostic
    Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis.
    Treglia G et al.
  28. 15 Feb 2012· European journal of cancer (Oxford, England· Ra-223· Therapeutic
    A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer.
    Nilsson S et al.
  29. 11 Feb 2012· International journal of radiation oncology, biology, physics· Gold-anchor fiducial markers· Therapeutic
    Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.
    Zelefsky MJ et al.
  30. 8 Feb 2012· Radiation oncology (London, England)· Thermoplastic masks· QA & dosimetry· Free full text
    Assessment of shoulder position variation and its impact on IMRT and VMAT doses for head and neck cancer.
    Neubauer E et al.
  31. 1 Feb 2012· European journal of nuclear medicine and molecular imaging· Cyclotron production· Diagnostic
    ⁶⁸Ga-labelled peptides for diagnosis of gastroenteropancreatic NET.
    Ambrosini V et al.
  32. 1 Feb 2012· European journal of nuclear medicine and molecular imaging· Lu-177 DOTATATE· Therapeutic· Free full text
    Lutetium-labelled peptides for therapy of neuroendocrine tumours.
    Kam BL et al.
  33. 31 Jan 2012· International journal of radiation oncology, biology, physics· In-vivo dosimetry· QA & dosimetry
    In vivo dosimetry for single-fraction targeted intraoperative radiotherapy (TARGIT) for breast cancer.
    Eaton DJ et al.
  34. 30 Jan 2012· Practical radiation oncology· SRS / intracranial· Therapeutic· Free full text
    Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline.
    Tsao MN et al.
  35. 23 Jan 2012· Acta oncologica (Stockholm, Sweden)· Vacuum cushions· QA & dosimetry
    Translational and rotational intra- and inter-fractional errors in patient and target position during a short course of frameless stereotactic body radiotherapy.
    Josipovic M et al.
  36. 9 Jan 2012· Radiation research· SBRT delivery· Therapeutic
    Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS).
    Park HJ et al.
  37. 1 Jan 2012· World journal of nuclear medicine· I-131 therapy· Theranostic· Free full text
    Radioiodine thyroid ablation in graves' hyperthyroidism: merits and pitfalls.
    Nwatsock JF et al.
  38. 30 Dec 2011· Proceedings of the National Academy of Sciences of the United States of America· Cyclotron production· Radiopharmacy
    Micro-chemical synthesis of molecular probes on an electronic microfluidic device.
    Keng PY et al.
  39. 16 Dec 2011· Acta oncologica (Stockholm, Sweden)· Breast / lung positioning· Therapeutic
    Radiation during deep inspiration allows loco-regional treatment of left breast and axillary-, supraclavicular- and internal mammary lymph nodes without compromising target coverage or dose restrictions to organs at risk.
    Hjelstuen MH et al.
  40. 13 Dec 2011· International journal of radiation oncology, biology, physics· SBRT delivery· Therapeutic
    Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study.
    Milano MT et al.
  41. 6 Dec 2011· Tumour biology· Ac-225 alpha therapy· Therapeutic
    An overview of targeted alpha therapy.
    Kim YS et al.
  42. 5 Dec 2011· Trials· Gold-anchor fiducial markers· Therapeutic· Free full text
    Single blind randomized phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial.
    Lips IM et al.
  43. 2 Dec 2011· International journal of radiation oncology, biology, physics· Adaptive radiotherapy· Therapeutic
    Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial.
    Schwartz DL et al.
  44. 1 Dec 2011· Journal of thoracic oncology· Breast / lung positioning· Therapeutic· QA & dosimetry
    Respiratory gating techniques for optimization of lung cancer radiotherapy.
    Giraud P et al.
  45. 1 Dec 2011· Medical physics· Linac QA· QA & dosimetry
    Implementing a newly proposed Monte Carlo based small field dosimetry formalism for a comprehensive set of diode detectors.
    Cranmer-Sargison G et al.
  46. 21 Nov 2011· The Journal of clinical investigation· I-131 therapy· Therapeutic
    Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation.
    Chakravarty D et al.
  47. 17 Nov 2011· Radiotherapy and oncology· Thermoplastic masks· QA & dosimetry
    Clinical comparison of positional accuracy and stability between dedicated versus conventional masks for immobilization in cranial stereotactic radiotherapy using 6-degree-of-freedom image guidance system-integrated platform.
    Ohtakara K et al.
  48. 9 Nov 2011· Journal of nuclear medicine· Ga-68 DOTATATE· Diagnostic
    68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors.
    Poeppel TD et al.
  49. 1 Nov 2011· JAMA· SRS / intracranial· Therapeutic
    Treatment of brain arteriovenous malformations: a systematic review and meta-analysis.
    van Beijnum J et al.
  50. 31 Oct 2011· Clinical cancer research· Ga-68 PSMA PET· Diagnostic
    2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer.
    Chen Y et al.
  51. 5 Oct 2011· The British journal of radiology· Hot-lab shielding· Radiation safety
    Radiation protection in fixed PET/CT facilities--design and operation.
    Peet DJ et al.
  52. 1 Oct 2011· Medical physics· Patient-specific QA· QA & dosimetry
    Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA.
    Zhen H et al.
  53. 1 Oct 2011· Current radiopharmaceuticals· Ac-225 alpha therapy· Therapeutic
    Actinium-225 in targeted alpha-particle therapeutic applications.
    Scheinberg DA et al.
  54. 24 Sept 2011· Radiotherapy and oncology· Patient-specific QA· QA & dosimetry
    Radiation therapy with unflattened photon beams: dosimetric accuracy of advanced dose calculation algorithms.
    Kragl G et al.
  55. 22 Sept 2011· International journal of radiation oncology, biology, physics· 6DoF head positioning· QA & dosimetry· Therapeutic
    Clinical evaluation of a robotic 6-degree of freedom treatment couch for frameless radiosurgery.
    Gevaert T et al.
  56. 19 Sept 2011· Prostate cancer· Diagnostic· Free full text
    Laparoscopic sentinel lymph node biopsy for prostate cancer: the relevance of locations outside the extended dissection area.
    Meinhardt W et al.
  57. 3 Sept 2011· European journal of nuclear medicine and molecular imaging· Lu-177 DOTATATE· Therapeutic
    Peptide receptor radionuclide therapy with ¹⁷⁷Lu-DOTATATE: the IEO phase I-II study.
    Bodei L et al.
  58. 1 Sept 2011· Medical physics· Linac QA· QA & dosimetry
    Implementing RapidArc into clinical routine: a comprehensive program from machine QA to TPS validation and patient QA.
    Van Esch A et al.
  59. 1 Sept 2011· Hellenic journal of nuclear medicine· Diagnostic
    Comparison between one day and two days protocols for sentinel node mapping of breast cancer patients.
    Ali J et al.
  60. 26 Aug 2011· Physics in medicine and biology· In-vivo dosimetry· QA & dosimetry
    Optically stimulated luminescence in vivo dosimetry for radiotherapy: physical characterization and clinical measurements in (60)Co beams.
    Mrčela I et al.